Introduction

Belching, also termed eructation, is the audible expulsion of air from the esophagus or stomach through the mouth. It is a universal physiological phenomenon that normally serves to vent swallowed air and intragastric gas produced during digestion. In most individuals, occasional belching occurs several times per day and is neither bothersome nor clinically significant. However, a subset of patients experiences belching that is so frequent, disruptive, and socially disabling that it constitutes a distinct clinical disorder warranting formal diagnosis and targeted management.

The Rome IV classification, published in 2016, categorizes belching disorders under the gastroduodenal disorders (category B) as B2: Belching Disorders. Critically, Rome IV introduced a biologically meaningful subclassification based on the anatomical origin of the expelled air: B2a, Excessive Supragastric Belching (originating from the esophagus) and B2b, Excessive Gastric Belching (originating from the stomach). This distinction was a major advance over earlier Rome iterations, as the two subtypes have fundamentally different mechanisms, different clinical presentations, and, most importantly, respond to different therapeutic strategies.

Despite its high prevalence in gastroenterology clinics, excessive belching remains underrecognized and poorly understood by many clinicians. Patients are frequently dismissed, undertreated, or subjected to unnecessary investigations for organic disease. A structured, Rome IV-based diagnostic approach provides a clear framework for identifying the disorder, classifying the subtype, and initiating evidence-based management.

Classification Within the Rome IV Gastroduodenal Disorders

The Rome IV framework organizes gastroduodenal disorders as follows:

Code	Disorder
B1	Functional Dyspepsia (B1a: Postprandial Distress Syndrome; B1b: Epigastric Pain Syndrome)
B2	Belching Disorders (B2a: Excessive Supragastric Belching; B2b: Excessive Gastric Belching)
B3	Nausea and Vomiting Disorders (B3a: Chronic Nausea Vomiting Syndrome; B3b: Cyclic Vomiting Syndrome; B3c: Cannabinoid Hyperemesis Syndrome)
B4	Rumination Syndrome

The placement of belching disorders alongside functional dyspepsia, nausea/vomiting disorders, and rumination syndrome reflects the shared anatomical region (esophagus, stomach, proximal duodenum) and the overlapping pathophysiological mechanisms (disordered motility, visceral hypersensitivity, behavioral components) that characterize these conditions.

The Rome IV Diagnostic Criteria

The Rome IV definition of belching disorders requires all of the following core criteria to be met:

1. Bothersome belching from the esophagus or stomach: The belching is severe enough to impact on usual activities.
2. Belching occurs more than 3 days per week.
3. No structural disease likely to explain the symptoms: Routine investigations, including upper endoscopy when indicated, have not identified organic, systemic, or structural disease that accounts for the belching.

Temporal Requirements

In addition to the core criteria, the following temporal conditions must be satisfied:

• Criteria fulfilled for the last 3 months: The core criteria have been continuously met for at least the most recent 3 consecutive months.
• Symptom onset at least 6 months before diagnosis: The initial onset of bothersome belching must have occurred at least 6 months prior to the current evaluation.

The temporal requirements ensure that the diagnosis captures a chronic, established pattern of excessive belching rather than a transient or self-limited episode. Patients with new-onset belching of less than 6 months duration may still meet the criteria at a future assessment if symptoms persist.

Supportive Criteria

Rome IV identifies two supportive findings that strengthen the diagnosis and aid in subtype classification, though they are not formally required:

• Frequent, repetitive belching observed on clinical examination: Particularly supportive of excessive supragastric belching (B2a), as supragastric belches are characteristically rapid, repetitive, and often occur in clusters that can be directly witnessed during a clinic visit.
• Impedance monitoring confirms the belching type: Intraluminal impedance measurement is the gold standard for distinguishing supragastric from gastric belching and provides objective confirmation of the diagnosis and subtype.

Subtype Classification: Supragastric vs. Gastric Belching

The cornerstone of the Rome IV approach to belching disorders is the distinction between supragastric and gastric belching. These are fundamentally different phenomena with different mechanisms, and conflating them leads to diagnostic confusion and therapeutic failure.

B2a: Excessive Supragastric Belching

Supragastric belching (SGB) is a behavioral phenomenon in which air is sucked or injected into the esophagus and immediately expelled before it reaches the stomach. The air never enters the gastric cavity. The mechanism involves a rapid sequence of events: the diaphragm descends or the pharynx contracts, creating negative intrathoracic or positive pharyngeal pressure that drives air into the esophagus; the upper esophageal sphincter then relaxes and the air is expelled orally, producing an audible belch.

Key clinical features of supragastric belching include:

• Very high frequency: Patients may produce dozens to hundreds of supragastric belches per hour, far exceeding any plausible volume of swallowed air.
• Repetitive, rapid-fire pattern: Belches often occur in rapid clusters with little pause between events. This repetitive pattern is often directly observable during the clinical encounter.
• Absent during sleep and distraction: Because SGB is a behavioral (learned) phenomenon, it characteristically ceases during sleep and typically diminishes markedly when the patient is distracted or engaged in conversation. This feature is a powerful clinical clue.
• Association with psychological distress: SGB is strongly associated with anxiety, obsessive-compulsive traits, and somatization. It may initially develop as a response to a perceived sensation of bloating, gas, or abdominal discomfort, and becomes self-perpetuating through a feedback loop in which the belching itself produces further aerophagia and esophageal discomfort.
• No relationship to meals: Unlike gastric belching, SGB does not increase postprandially because it is not driven by intragastric gas.

B2b: Excessive Gastric Belching

Gastric belching is the physiological venting of gas from the stomach through transient lower esophageal sphincter relaxations (TLESRs). Every healthy individual produces gastric belches, particularly after meals, as a normal venting mechanism for swallowed air and gas generated by gastric acid neutralization of bicarbonate. Gastric belching becomes pathological when it is excessive in frequency, bothersome to the patient, and not explained by structural disease.

Key clinical features of excessive gastric belching include:

• Postprandial predominance: Gastric belching is driven by intragastric gas volume and therefore increases after meals, particularly large meals, carbonated beverages, and gas-producing foods.
• Lower frequency than supragastric belching: While bothersome, excessive gastric belching rarely reaches the extreme frequencies seen in SGB (dozens per hour).
• Single belches rather than rapid clusters: Gastric belches tend to occur as isolated events rather than the rapid-fire clusters characteristic of SGB.
• Present during sleep (rare but possible): Because the mechanism involves reflexive TLESRs, gastric belching is not entirely behavior-dependent and can theoretically occur during sleep, although this is uncommon.
• Associated with aerophagia: Excessive air swallowing (aerophagia), which increases intragastric gas volume and triggers more frequent TLESRs, is a common contributing factor in excessive gastric belching.

Comparison of Supragastric and Gastric Belching

Feature	Supragastric Belching (B2a)	Gastric Belching (B2b)
Origin of air	Esophagus (air never reaches the stomach)	Stomach (air vented via TLESR)
Mechanism	Behavioral; air sucked/injected into esophagus and immediately expelled	Physiological reflex (TLESR); becomes excessive due to increased intragastric gas
Frequency	Very high (often dozens to hundreds per hour)	Moderately elevated above normal
Pattern	Rapid, repetitive clusters	Isolated, single belches
Relationship to meals	No consistent postprandial increase	Postprandially predominant
Behavior during sleep	Absent	Rare but possible
Response to distraction	Markedly reduced	Minimal change
Impedance pattern	Rapid antegrade-then-retrograde flow without preceding gastric gas rise	Retrograde gas flow from stomach preceded by TLESR
Primary treatment	Behavioral therapy (speech therapy, CBT)	Dietary modification, TLESR reducers (baclofen)

The Physiology of Normal Belching

Understanding normal belching physiology provides essential context for appreciating the pathological states defined by Rome IV.

Sources of Intragastric Gas

Intragastric gas accumulates from three primary sources:

• Swallowed air (aerophagia): Every swallow carries a small bolus of air (2 to 5 mL) into the esophagus and stomach. Normal individuals swallow approximately 600 times per day, introducing a cumulative volume of several liters of air daily. Anxiety, rapid eating, gum chewing, smoking, poorly fitting dentures, and carbonated beverage consumption all increase aerophagia.
• Chemical gas production: The reaction of gastric hydrochloric acid with bicarbonate (from saliva, pancreatic secretions, and duodenal reflux) produces carbon dioxide. Approximately 2 to 3 liters of CO2 are produced daily in the proximal gastrointestinal tract.
• Diffusion from blood: Gas can diffuse into the gastric lumen from the bloodstream along concentration gradients, though this contributes relatively little to total intragastric gas volume.

The Gastric Belch Reflex

The normal gastric belch reflex is triggered by distension of the gastric fundus, which activates mechanoreceptors that signal through vagal afferents to the brainstem. This triggers a transient lower esophageal sphincter relaxation (TLESR), a coordinated event in which the lower esophageal sphincter relaxes simultaneously with inhibition of the crural diaphragm, allowing gas (but ideally not liquid gastric contents) to escape from the stomach into the esophagus and then through the upper esophageal sphincter. A normal individual produces approximately 25 to 30 gastric belches per day, predominantly in the postprandial period.

The Supragastric Belch Mechanism

Unlike the reflex-driven gastric belch, the supragastric belch is a voluntary or semi-voluntary action, even though many patients are unaware they are performing it. Two distinct mechanisms have been documented on impedance monitoring and fluoroscopy:

• Air suction: The patient generates negative intrathoracic pressure (by contracting the diaphragm while the glottis is closed), which sucks air through the relaxed upper esophageal sphincter into the esophageal body. The air is then immediately expelled.
• Air injection: The patient generates positive pharyngeal pressure (by contracting the pharyngeal musculature against a closed glottis, similar to the Valsalva maneuver in reverse), which forces air into the esophagus through the upper esophageal sphincter.

In both cases, the air enters and exits the esophagus without crossing the lower esophageal sphincter into the stomach. The entire sequence, from air entry to audible expulsion, often occurs in less than one second, allowing the characteristic rapid-fire repetitive pattern.

Epidemiology

Precise epidemiological data on belching disorders are limited because belching is infrequently reported as a primary complaint and because population-based studies using Rome IV subtype criteria are scarce. Available data suggest the following:

• Belching is one of the most common upper gastrointestinal symptoms reported in community surveys, with prevalence rates of 20 to 30 percent when patients are asked about bothersome belching. However, most of these individuals do not meet the full Rome IV criteria for a belching disorder (which require impact on usual activities, frequency greater than 3 days per week, and 6-month symptom onset).
• Among patients referred to gastroenterology clinics for excessive belching, supragastric belching is the more common subtype, accounting for approximately 60 to 80 percent of cases in referral populations.
• Belching disorders affect both sexes, though some studies suggest a slight female predominance. They can present at any age but are most commonly diagnosed in adults between 30 and 60.
• Excessive belching frequently coexists with other functional gastrointestinal disorders, particularly functional dyspepsia (30 to 50 percent overlap) and gastroesophageal reflux disease (up to 40 percent of GERD patients report bothersome belching).

The social and psychological impact of excessive belching is substantial. Patients report embarrassment, social withdrawal, avoidance of public eating, workplace difficulties, and significant impairment in quality of life. The involuntary and audible nature of belching makes it uniquely socially stigmatizing among functional gastrointestinal symptoms.

Pathophysiology

Supragastric Belching: A Learned Behavioral Disorder

Supragastric belching is now understood as a learned behavioral response that typically develops in the context of a perceived need to relieve abdominal or esophageal discomfort. The proposed sequence is as follows:

1. The patient experiences an uncomfortable sensation in the upper abdomen or chest (bloating, fullness, pressure, or a vague sense of gas).
2. The patient, either consciously or subconsciously, discovers that a belching-like maneuver produces a sensation of temporary relief (likely through esophageal distension and subsequent decompression, which may activate vagal afferents that modulate discomfort perception).
3. Through operant conditioning, the belching behavior is reinforced by the transient relief it provides.
4. Over time, the behavior becomes habitual and increasingly automatic, occurring with minimal or no conscious awareness. The patient genuinely does not realize they are actively producing the belches.
5. A vicious cycle develops: supragastric belching introduces additional air into the esophagus and (via some air escaping distally) the stomach, producing further bloating and discomfort, which triggers more belching.

Psychological factors play an important facilitating role. Anxiety increases somatic awareness and lowers the threshold at which normal interoceptive signals are perceived as uncomfortable, making it more likely that the patient will seek relief through belching. Stress, obsessive-compulsive tendencies, and somatization are all overrepresented in SGB populations.

Gastric Belching: Dysregulated Physiological Venting

Excessive gastric belching results from an imbalance between intragastric gas accumulation and the physiological venting capacity. Contributing factors include:

• Increased aerophagia: Excessive air swallowing increases intragastric gas volume and triggers more frequent TLESRs. Aerophagia may be a standalone entity (Rome IV does not classify it separately in adults) or may contribute to excessive gastric belching.
• Dietary factors: Carbonated beverages, gas-producing foods (legumes, cruciferous vegetables, onions), and rapid eating increase intragastric gas production and swallowed air volume.
• Impaired gastric accommodation: The proximal stomach normally relaxes to accommodate a meal (gastric accommodation). When this reflex is impaired, as in some patients with functional dyspepsia, even normal volumes of intragastric gas produce excessive fundic distension, triggering more TLESRs and more frequent belching.
• Increased TLESR frequency: Some patients have an inherently higher rate of TLESRs, leading to more frequent gas venting even with normal intragastric gas volumes. This may be mediated by altered vagal signaling or gamma-aminobutyric acid (GABA) receptor sensitivity at the level of the brainstem.

Diagnostic Workup

Clinical History and Observation

The clinical history is the most important initial step in evaluating a patient with excessive belching. Key questions include:

• How frequently does belching occur? (Quantify as episodes per hour or per day if possible.)
• Does the belching occur in rapid clusters or as isolated events?
• Is the belching worse after meals or unrelated to meals?
• Does the belching stop during sleep? (Ask the bed partner if available.)
• Does the belching diminish when the patient is focused on a task or distracted?
• Does the patient feel a need to belch to relieve discomfort, or do the belches occur involuntarily?
• Are there associated symptoms such as bloating, abdominal pain, chest discomfort, heartburn, dysphagia, or nausea?
• What is the impact on daily activities, work, social interactions, and quality of life?

Direct observation during the consultation is invaluable. Supragastric belching is often clearly audible and visible during the clinic visit: the characteristic rapid, repetitive, often explosive bursts of belching that occur throughout the encounter are virtually diagnostic. Noting whether the belching stops when the patient is distracted by a cognitive task (such as counting backward from 100 by sevens) provides powerful clinical evidence for SGB.

Exclusion of Structural Disease

The Rome IV criteria require that no structural disease likely to explain the symptoms has been identified. The extent of the workup should be guided by the clinical presentation and the presence or absence of alarm features. Commonly considered investigations include:

• Upper endoscopy (EGD): Indicated when there is diagnostic uncertainty or when alarm features are present (dysphagia, odynophagia, weight loss, anemia, age >50 with new-onset symptoms). EGD excludes esophageal and gastric mucosal disease, obstruction, and hiatal hernia as contributors to belching.
• Abdominal imaging: Not routinely required but may be considered if symptoms suggest small bowel obstruction, gastroparesis, or other structural pathology.
• Helicobacter pylori testing: H. pylori infection can cause dyspepsia and may contribute to altered gastric gas dynamics. Testing and treatment, if positive, are reasonable in the initial workup.
• Gastric emptying study: If there is clinical suspicion for gastroparesis (nausea, vomiting, early satiety, postprandial fullness), delayed gastric emptying should be excluded, as it can contribute to gastric distension and belching.

Impedance Monitoring: The Gold Standard for Subtyping

Intraluminal impedance monitoring is the definitive diagnostic tool for distinguishing supragastric from gastric belching. During impedance monitoring, a catheter with multiple impedance electrodes is placed in the esophagus and records changes in intraluminal impedance caused by the passage of gas, liquid, or mixed content. The direction of gas movement (antegrade from pharynx to esophagus vs. retrograde from stomach to esophagus) and the involvement of the lower esophageal sphincter can be precisely characterized.

Impedance Patterns

Belch Type	Impedance Signature
Supragastric belch	Rapid increase in impedance (indicating gas entry) that progresses antegrade (from proximal to distal esophagus), immediately followed by a retrograde impedance increase (gas expelled from distal to proximal and out through the mouth). The gas never crosses the lower esophageal sphincter. No preceding TLESR.
Gastric belch	Impedance increase that progresses retrograde (from distal to proximal esophagus), originating below the lower esophageal sphincter. A preceding TLESR is typically observed on concurrent manometry. Gas traverses the full length of the esophagus.

Combined impedance-pH-manometry studies provide the most comprehensive characterization, simultaneously documenting belch type, reflux events, and esophageal motor function. However, the standard 24-hour impedance-pH catheter is sufficient for subtype classification in most cases.

Impedance monitoring also quantifies the total number of belches, the ratio of supragastric to gastric belches, and the temporal distribution of belching events (meal-related vs. fasting, daytime vs. nighttime). A normal individual produces fewer than 13 supragastric belches per 24 hours on impedance monitoring. Patients with excessive supragastric belching commonly produce 50 to over 300 supragastric belches per 24 hours.

Differential Diagnosis

Before applying the Rome IV belching disorder criteria, the following conditions should be considered and excluded as appropriate.

Aerophagia

Aerophagia refers to excessive, repetitive air swallowing that leads to abdominal distension, bloating, and increased flatus and belching. While Rome IV does not classify adult aerophagia as a separate functional gastroduodenal disorder (it is included in the pediatric classification as H2a), the concept remains clinically relevant. Aerophagia contributes to excessive gastric belching by increasing intragastric gas volume. It is distinguished from supragastric belching by the fact that swallowed air in aerophagia actually enters the stomach (and often the small bowel), whereas in SGB the air never crosses the lower esophageal sphincter.

Gastroesophageal Reflux Disease (GERD)

Belching is a common symptom in GERD patients, both as a coexisting complaint and as a mechanistic contributor. TLESRs, which mediate gastric belching, are also the primary mechanism of acid reflux in GERD. Some GERD patients develop supragastric belching as a behavioral response to reflux-related discomfort. When belching is the dominant complaint in a GERD patient, the Rome IV belching disorder criteria can be applied alongside the GERD diagnosis.

Gastroparesis

Delayed gastric emptying leads to prolonged gastric retention of food and gas, producing bloating, nausea, early satiety, and belching. Gastroparesis should be considered when belching is accompanied by significant nausea, vomiting, or postprandial fullness, particularly in patients with diabetes mellitus, prior gastric surgery, or use of medications that slow gastric motility (opioids, anticholinergics, GLP-1 receptor agonists).

Small Intestinal Bacterial Overgrowth (SIBO)

Excessive bacterial fermentation in the small intestine produces hydrogen, methane, and carbon dioxide, which can reflux into the stomach and contribute to belching, bloating, and flatulence. SIBO should be considered when belching is accompanied by diarrhea, bloating, and malabsorption symptoms, particularly in patients with predisposing conditions (prior bowel surgery, small bowel diverticula, dysmotility, immunodeficiency).

Functional Dyspepsia

Functional dyspepsia frequently coexists with belching disorders. Patients with postprandial distress syndrome (Rome IV B1a) may report belching as part of a constellation of symptoms that includes early satiety, postprandial fullness, and epigastric discomfort. When both conditions are present, both diagnoses should be recorded, as this may influence management priorities.

Rumination Syndrome

Rumination involves the effortless, repetitive regurgitation of recently ingested food into the mouth, followed by re-chewing, re-swallowing, or spitting. While the mechanics differ from belching, some patients describe the regurgitation episodes as "belching up food." Impedance monitoring can help distinguish rumination (retrograde liquid/mixed flow from stomach to pharynx) from belching (gas movement).

Structural and Organic Causes

• Hiatal hernia: Large hiatal hernias can alter the mechanics of the gastroesophageal junction and increase the frequency of both reflux and belching.
• Gastric outlet obstruction: Pyloric stenosis (from peptic ulcer disease, malignancy, or congenital causes) leads to gastric distension, nausea, vomiting, and excessive belching.
• Esophageal diverticula: Zenker's diverticulum and mid-esophageal diverticula can trap air and produce belching-like symptoms.
• Pancreatic and biliary disease: Rarely, pancreatic insufficiency or biliary disease produces bloating and belching through maldigestion and altered gas dynamics.

Management

The management of belching disorders is guided by subtype classification. Treating supragastric belching with the same approach used for gastric belching is a common cause of therapeutic failure and patient frustration.

Management of Excessive Supragastric Belching (B2a)

Because supragastric belching is a behavioral disorder, treatment centers on behavioral modification rather than pharmacotherapy.

Behavioral Therapy and Speech Therapy

Behavioral therapy, often delivered by a speech-language pathologist with expertise in upper aerodigestive tract disorders, is the first-line and most effective treatment for SGB. The therapeutic approach typically includes:

• Education and awareness: Explaining the mechanism of SGB to the patient (that the belches originate from the esophagus, not the stomach, and are produced by a learned physical maneuver) is itself therapeutic. Many patients are skeptical that their belching could be behavioral, as it feels involuntary. Video feedback from impedance monitoring or fluoroscopy can be powerfully persuasive.
• Diaphragmatic breathing: Teaching the patient to engage in slow, deep diaphragmatic breathing is the core behavioral intervention. Diaphragmatic breathing physically opposes the mechanism of SGB: when the diaphragm is actively engaged in a controlled descent during inhalation, it cannot simultaneously be used to generate the negative intrathoracic pressure required to suck air into the esophagus. Patients are instructed to practice diaphragmatic breathing whenever they feel the urge to belch, and to incorporate it into daily routines (5 to 10 minutes, three to four times daily).
• Habit reversal training: Patients are taught to recognize the premonitory urge or sensation that precedes each belch and to substitute a competing response (diaphragmatic breathing, swallowing suppression, jaw positioning) that is physically incompatible with the belching maneuver.
• Biofeedback: In some centers, biofeedback using electromyographic (EMG) monitoring of the diaphragm and/or real-time impedance display helps patients visualize and gain conscious control over the muscle actions involved in SGB.

Clinical trials and case series have reported symptom improvement in 50 to 80 percent of SGB patients treated with behavioral therapy, with some studies demonstrating sustained benefit at 6 to 12-month follow-up.

Cognitive Behavioral Therapy (CBT)

CBT addresses the psychological factors that perpetuate SGB, including anxiety, hypervigilance to somatic sensations, catastrophizing, and avoidance behaviors. CBT is particularly valuable when significant psychological comorbidity is present or when behavioral therapy alone is insufficient.

Pharmacotherapy for SGB

Pharmacotherapy has a limited role in SGB but may be used as adjunctive treatment:

• Baclofen (5 to 10 mg three times daily): This GABA-B receptor agonist reduces the frequency of TLESRs and has shown modest benefit in some SGB patients, possibly by modulating the esophageal motor events associated with air entry. Side effects (drowsiness, dizziness) limit its use.
• Anxiolytics and neuromodulators: When anxiety is a prominent driver, low-dose tricyclic antidepressants (amitriptyline 10 to 25 mg at bedtime) or SSRIs may reduce the anxiety-driven somatic hypervigilance that perpetuates the belching cycle.

Management of Excessive Gastric Belching (B2b)

Management of excessive gastric belching targets the underlying causes of increased intragastric gas and the reflexes responsible for its expulsion.

Dietary Modification

• Reduce or eliminate carbonated beverages, which directly introduce CO2 into the stomach.
• Minimize consumption of gas-producing foods (beans, lentils, broccoli, cabbage, onions, wheat, certain fruits).
• Eat slowly and chew thoroughly to reduce aerophagia.
• Avoid chewing gum and sucking on hard candy, both of which increase swallowed air.
• Limit use of drinking straws, which increase air ingestion.
• Consider a trial of low-FODMAP diet if concomitant bloating and flatulence suggest excessive fermentation.

Behavioral Measures to Reduce Aerophagia

• Conscious effort to swallow less frequently and to avoid "dry swallowing" (swallowing saliva repeatedly when not eating).
• Smoking cessation (smoking increases air swallowing).
• Address poorly fitting dentures or other dental issues that may promote excessive swallowing.
• Avoid talking while eating, which increases aerophagia.

Pharmacotherapy for Gastric Belching

Agent	Mechanism	Notes
Baclofen (10 to 20 mg three times daily)	GABA-B receptor agonist; reduces TLESR frequency by 40 to 60%	Most evidence-based pharmacological option for gastric belching and GERD-associated belching. CNS side effects (somnolence, dizziness) are dose-limiting.
Simethicone	Anti-foaming agent; breaks up gas bubbles in the stomach, facilitating their coalescence and passage	Safe and widely available over the counter; modest efficacy at best; may provide symptomatic relief in combination with other measures.
Prokinetics (domperidone, metoclopramide)	Accelerate gastric emptying, reducing the time that gas-generating reactions occur in the stomach	Consider when there is evidence of delayed gastric emptying contributing to belching. Use with caution due to side effect profiles (extrapyramidal effects with metoclopramide, cardiac risk with domperidone).
Proton pump inhibitors	Reduce gastric acid secretion, thereby reducing the volume of CO2 generated by acid-bicarbonate neutralization	May have a modest effect on postprandial gas volume. Not a first-line treatment for belching but may help when GERD coexists.

The Role of Psychological Comorbidity

Psychological comorbidity is particularly prominent in supragastric belching but can be present in both belching subtypes. Commonly observed psychological features include:

• Generalized anxiety disorder: Present in 40 to 60 percent of SGB patients in clinical series. Anxiety drives somatic hypervigilance and increases the likelihood that normal interoceptive signals are perceived as threatening, prompting the belching behavior.
• Obsessive-compulsive features: Some patients develop an obsessive focus on the belching itself, monitoring its frequency, worrying about its social impact, and engaging in compulsive behaviors (such as throat clearing or swallowing rituals) in an attempt to control it.
• Somatization and health anxiety: Patients with somatization disorder or health anxiety may present with belching as one of multiple unexplained somatic symptoms. The belching may amplify health-related worry, creating a self-reinforcing cycle.
• Depression: The social isolation, embarrassment, and functional impairment caused by excessive belching can precipitate or exacerbate depressive symptoms.

Screening for anxiety and depression using validated instruments (such as the GAD-7 and PHQ-9) should be part of the initial evaluation of any patient with a belching disorder. When significant psychological comorbidity is identified, integrated management that combines behavioral therapy for the belching with psychological treatment for the comorbid condition produces the best outcomes.

Overlap with Other Functional Gastrointestinal Disorders

Belching disorders frequently coexist with other Rome IV functional gastrointestinal conditions, reflecting shared pathophysiological mechanisms across the gut-brain axis.

• Functional dyspepsia (B1): The most common overlap, present in 30 to 50 percent of belching disorder patients. Shared mechanisms include impaired gastric accommodation, visceral hypersensitivity, and increased aerophagia. Both conditions may respond to prokinetics and neuromodulators.
• Gastroesophageal reflux disease: Up to 40 percent of GERD patients report bothersome belching, and TLESRs are the shared mechanism for both gastric belching and acid reflux. Some GERD patients develop secondary supragastric belching as a maladaptive behavioral response to reflux-related discomfort.
• Irritable bowel syndrome (IBS): Belching is reported by 20 to 30 percent of IBS patients, particularly those with IBS-C and bloating-predominant symptoms. The co-occurrence likely reflects generalized visceral hypersensitivity and altered gastrointestinal motility.
• Rumination syndrome (B4): Some patients exhibit features of both supragastric belching and rumination, as both involve learned behaviors affecting the upper gastrointestinal tract. Impedance monitoring can help delineate the relative contributions of each.
• Globus (A4): The sensation of a lump in the throat may coexist with belching disorders, particularly SGB, where repeated air passage through the upper esophageal sphincter may produce pharyngeal discomfort and globus sensation.

Historical Evolution: Rome III to Rome IV

The Rome III criteria (2006) did not formally subclassify belching disorders into supragastric and gastric subtypes. Rome III recognized "aerophagia" as a distinct functional gastroduodenal disorder (defined as objectively observed or measured repetitive air swallowing with abdominal distension), but the broader category of excessive belching was not well defined. This lack of subclassification hampered clinical management, as supragastric and gastric belching were often treated identically despite their fundamentally different mechanisms.

Rome IV corrected this by:

• Creating a dedicated category (B2) for belching disorders with explicit diagnostic criteria.
• Introducing the supragastric (B2a) and gastric (B2b) subclassification, driven by the impedance monitoring literature that had clearly demonstrated two distinct belching mechanisms.
• Removing adult aerophagia as a standalone category (retaining it only in the pediatric classification) and instead incorporating excessive air swallowing as a contributing factor to excessive gastric belching.
• Defining clear frequency (more than 3 days per week) and severity (impact on usual activities) thresholds to distinguish pathological belching from normal physiological eructation.

Special Populations

Pediatric Patients

In children, the Rome IV classification retains aerophagia as a separate entity (H2a: Aerophagia), recognizing that excessive air swallowing in children often presents differently from adult belching disorders. Pediatric aerophagia typically manifests with abdominal distension, flatulence, and belching in the context of repetitive air swallowing, often associated with behavioral or developmental conditions. The adult B2a/B2b subclassification is generally applied from adolescence onward.

Post-Fundoplication Patients

Patients who have undergone anti-reflux surgery (Nissen or Toupet fundoplication) frequently report new-onset or worsened belching postoperatively. The fundoplication increases the resistance of the gastroesophageal junction to gas venting, which can produce a "gas-bloat syndrome" characterized by inability to belch, abdominal distension, and increased flatulence. Paradoxically, some post-fundoplication patients develop supragastric belching as a behavioral adaptation to the sensation of trapped gas that they cannot vent through normal gastric belching. Impedance monitoring is particularly valuable in this population to determine the mechanism of postoperative belching complaints.

Patients with Comorbid GERD

Managing belching in the context of coexisting GERD requires attention to both conditions. PPIs may improve acid reflux symptoms but do not address the belching, which is driven by TLESRs (for gastric belching) or behavioral mechanisms (for SGB). Baclofen, which reduces TLESRs, may simultaneously improve both acid reflux and gastric belching. When SGB coexists with GERD, behavioral therapy for the belching should be pursued alongside reflux-directed treatment.

Limitations of the Rome IV Criteria for Belching Disorders

• Impedance monitoring accessibility: While impedance monitoring is the gold standard for subtype classification, it is not universally available. The Rome IV criteria allow a clinical diagnosis of belching disorder without impedance monitoring, but accurate subtyping may be compromised in settings without access to this technology.
• Subjective severity threshold: The criterion that belching must be "severe enough to impact usual activities" is inherently subjective and may be interpreted differently by different patients and clinicians. There is no validated severity scale specifically for belching disorders.
• Frequency threshold: The threshold of more than 3 days per week was consensus-derived rather than evidence-based. Some patients with highly bothersome belching on fewer than 3 days per week may not meet criteria despite significant impairment.
• Mixed presentations: Some patients exhibit both supragastric and gastric belching (mixed belching), and the Rome IV criteria do not provide specific guidance for this scenario. Impedance monitoring may show a predominance of one type, but management of mixed cases can be challenging.
• Overlap with aerophagia: The removal of adult aerophagia as a standalone Rome IV category creates some ambiguity for patients whose primary issue is excessive air swallowing with resultant abdominal distension, bloating, and flatulence, with belching as a secondary rather than primary symptom.
• Limited treatment evidence: The evidence base for treatments of belching disorders, particularly gastric belching, is relatively thin compared to other functional gastrointestinal disorders. Most therapeutic recommendations are based on small trials, case series, and expert opinion.

Practical Pearls for Clinical Use

• Observe the patient during the visit. Supragastric belching is often immediately apparent in the clinic: rapid, repetitive belching throughout the consultation is virtually diagnostic and may obviate the need for impedance monitoring in many cases.
• Ask about sleep. If the patient or their bed partner confirms that belching stops completely during sleep, supragastric belching is overwhelmingly likely. Gastric belching can occasionally occur during sleep, though this is uncommon.
• Test with distraction. During the consultation, engage the patient in a cognitively demanding task (serial subtraction, detailed history taking on an unrelated topic). If belching frequency drops markedly, this strongly supports SGB.
• Do not reflexively perform endoscopy in every patient. Young patients (<50) with classic symptoms of excessive belching, no alarm features, and an observable pattern consistent with SGB may not require EGD before applying the Rome IV criteria. Reserve endoscopy for cases with diagnostic uncertainty or alarm features.
• Explain the mechanism to the patient. Patients with SGB often resist the idea that their belching is behavioral. A compassionate, non-judgmental explanation that SGB is a learned physical reflex (like hiccups or a tic) rather than a psychiatric condition improves acceptance and engagement with behavioral therapy.
• Refer to a speech-language pathologist early. For SGB, behavioral therapy delivered by an experienced speech therapist is the most effective treatment. Delaying this referral in favor of empiric pharmacotherapy is a common cause of prolonged suffering.
• Document subtype. Recording the subtype (B2a or B2b) in the medical record is essential for treatment planning. Treating SGB with dietary modification and prokinetics is futile; treating gastric belching with speech therapy alone is similarly misdirected.
• Screen for psychological comorbidity. Anxiety screening with the GAD-7 and depression screening with the PHQ-9 should be routine in the evaluation of belching disorders. Addressing comorbid anxiety or depression significantly improves treatment response.
• Address overlapping conditions. When belching coexists with functional dyspepsia, GERD, or IBS, all conditions should be addressed. Treating the belching disorder in isolation while ignoring a coexisting condition (or vice versa) leads to incomplete symptom relief and patient dissatisfaction.
• Set realistic expectations. Behavioral therapy for SGB is effective but requires sustained practice and patience. Patients should understand that improvement is gradual and that daily diaphragmatic breathing exercises must be maintained for several weeks before significant benefit is expected.